
Tell your friends about this item:
Trends in Inflammatory Bowel Disease Therapy 1999: The proceedings of a symposium organized by AXCAN PHARMA, held in Vancouver, BC, August 27-29, 1999 2000 edition
Noel Williams
Trends in Inflammatory Bowel Disease Therapy 1999: The proceedings of a symposium organized by AXCAN PHARMA, held in Vancouver, BC, August 27-29, 1999 2000 edition
Noel Williams
This Trends in Inflammatory Bowel Disease Therapy Symposium was held in Vancouver, British Columbia, Canada, 27~29 August 1999. This is the seventh international symposium, sponsored by Axcan Pharma Canada Inc., since the first symposium in 1986.
Marc Notes: The proceedings of a symposium organised by Axcan Pharma, held in Vancouver, BC, August 27-29, 1999.; Trends in Inflammatory Bowel Disease Therapy Symposium--Pref.; Includes bibliographical references and index. Table of Contents: List of Principal Authors. Preface. Section I: Genetics. 1. Genetics of Inflammatory Bowel Disease: Where Are We? K. Siminovitch. 2. Genetics of Inflammatory Bowel Disease - Why is it Important? D. Jewell. 3. Genetics of IBD: Impact on Immune Function; C. Fiocchi. Section II: Pathogenesis. 4. Bacterial Factors in Inflammatory Bowel Disease Pathogenesis; W. Doe. 5. IBD: Autoimmunity or Chronic Inflammation? L. Mayer. 6. Neutrophil-Epithelial Interactions, and Efforts to Down-Regulate Them, in Inflammatory Bowel Disease; A. Gewirtz, J. L. Madara. 7. Understanding IBD at the Millennium: Tentative Answers and Future Questions; D. K. Podolsky. Section III: Clinical Challenges in IBD. 8. Diagnosis of Inflammatory Bowel Disease - An Update; M. Robinson. 9. Recent Developments in the Diagnosis and Management of Pediatric IBD; E. G. Seidman, et al. 10. Inflammatory Bowel Disease in the Elderly; G. R. Greenberg, I. Tai. Section IV: Current Therapy in IBD. 11. Therapy for Active Ulcerative Colitis; S. B. Hanauer. 12. Remission Maintenance in Ulcerative Colitis; J. Scholmerich. 13. Induction Therapy in Crohn's Disease; A. H. Steinhart. 14. Maintenance of Remission in Crohn's Disease; R. Rutgeerts. Section V: Bone Disease in IBD. 15. Risk Factors and Prevalence of Bone Disease in IBD. C. N. Bernstein. 16. The Management of Low Bone Mass in Patients with IBD; A. Tenenhouse. 17. Steroid Induced Osteonecrosis in IBD: CanadianLegal Status; R. M. Carter, M. G. A. Grace. Section VI: Alternative Therapy. 18. Psychotherapy for Inflammatory Bowel Disease: New Prospects; R. Maunder. 19. The Use of Complementary and Alternative Medicine by Patients with Inflammatory Bowel Disease; R. J. Hilsden, M. J. Verhoef. 20. Gut Inflammation: Is There a Role for Herbal Medicines? M. J. S. Miller. 21. The Role of Nutrition in the Treatment of IBD; M. A. Gassull. Section VII: New Therapeutic Approaches. 22. Antibodies to Proinflammatory Cytokines; L. C. Karp, S. R. Targan. 23. Immunomodulation of Crohn's Disease; C. van Montfrans, et al. 24. The Application of Recombinant DNA Technology to the Identification of Novel Therapeutic Targets in Inflammatory Bowel Disease; G. E. Wild, et al. 25. The Use of Probiotics in Inflammatory Bowel Disease; M. Campieri, et al. Index."
Media | Books Hardcover Book (Book with hard spine and cover) |
Released | February 29, 2000 |
ISBN13 | 9780792387626 |
Publishers | Springer |
Pages | 262 |
Dimensions | 155 × 235 × 17 mm · 589 g |
Language | English |
Editor | Bursey, R.F. |
Editor | Gall, D.G. |
Editor | Martin, F. |
Editor | McLeod, R.S. |
Editor | Sutherland, L.R. |
Editor | Wallace, J.L. |
Editor | Williams, C. Noel |
More by Noel Williams
See all of Noel Williams ( e.g. Paperback Book , Hardcover Book and Book )